https://sputnikglobe.com/20170907/rdif-jbic-stake-russian-pharma-1057162394.html

Russian Wealth Fund RDIF, Japanese Bank JBIC to Buy Stake in Russian Pharma Firm

Sputnik International

The RDIF, JBIC joint fund's first investment will be in a Russian pharmaceutical firm. 07.09.2017, Sputnik International

2017-09-07T00:58+0000

https://cdn1.img.sputnikglobe.com/img/105301/08/1053010801_0:431:2198:1674_1920x0_80_0_0_107ffcd59c62a19234fb97a7b74141b2.jpg

russia

japan

Sputnik International

feedback@sputniknews.com

+74956456601

MIA „Rosiya Segodnya“

252

2017

Sputnik International

feedback@sputniknews.com

+74956456601

MIA „Rosiya Segodnya“

252

News

en_EN

Sputnik International

feedback@sputniknews.com

+74956456601

MIA „Rosiya Segodnya“

252

1920

1080

true

1920

1440

true

https://cdn1.img.sputnikglobe.com/img/105301/08/1053010801_0:362:2198:1743_1920x0_80_0_0_71403eaed609f6923f64c85cea7a8454.jpg

1920

true

Sputnik International

feedback@sputniknews.com

+74956456601

MIA „Rosiya Segodnya“

252

Sputnik International

business, newsfeed, russia, japan

Russian Wealth Fund RDIF, Japanese Bank JBIC to Buy Stake in Russian Pharma Firm

00:58 GMT 07.09.2017

Recent advances in DNA sequencing have allowed researchers to map the genome of the anthrax discovered on the German spy. - Sputnik International

Go to the mediabank

The RDIF, JBIC joint fund's first investment will be in a Russian pharmaceutical firm.

VLADIVOSTOK (Sputnik) — The first investment of a joint fund run by the Russian Direct Investment Fund (RDIF) and Japan Bank for International Cooperation (JBIC) will be in a Russian pharmaceutical firm, the RDIF head said Thursday.

General Director of the Russian Direct Investment Fund Kirill Dmitriyev - Sputnik International

Russian Investment Fund, Japan’s JBIC to Achieve Some 10 Projects in Near Future

28 April 2017, 03:30 GMT

Speaking at the Eastern Economic Forum in the Russian Pacific port city of Vladivostok, RDIF CEO Kirill Dmitriyev said they were going to buy a stake in the R-Pharm company, in what is the first project in a slew of joint investment plans under scrutiny.

"We expect it to be a profitable, good investment," Dmitriyev said, adding more projects were related to medicine, as well as agriculture and other spheres.